Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.64
+0.03000.28%
Volume:42.56K
Turnover:452.83K
Market Cap:532.01M
PE:-8.97
High:10.70
Open:10.59
Low:10.55
Close:10.61
Loading ...
Mar 01, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 12, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K/A [Amend] - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Oct 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 19, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report